Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of HITS pilot/phase II study Meeting Abstract
| Authors: | Mora, J.; Kushner, B. H.; Flores, M. A.; Santa-Maria, V.; Garraus, M.; Basu, E. M.; Roberts, S. S.; Castaneda, A.; Gorostegui, M.; Cheung, N. K. V.; Modak, S. |
| Abstract Title: | Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of HITS pilot/phase II study |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 541s |
| Language: | English |
| ACCESSION: | WOS:000487345803615 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.10025 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 10025 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
